Considering that PD-1 and PD-L1 are important inhibitory checkpoint receptors whose abundant expression explains immune cell exhaustion, tumor progression and aggressiveness, we evaluated the expression of both molecules in AM and NACM. This evidence concerns the gene PDCD1 and neoplasm.